MARC details
000 -LEADER |
fixed length control field |
03820nam a22005055i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085909.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220210s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783030900656 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-030-90065-6 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Transcribing agency |
TR-AnTOB |
Description conventions |
rda |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WC 506.5 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJD |
Source |
bicssc |
|
Subject category code |
MED010000 |
Source |
bisacsh |
|
Subject category code |
MJD |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WC506.5EBK |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Mallick, Umair. |
Relator term |
author. |
Relator code |
aut |
-- |
http://id.loc.gov/vocabulary/relators/aut |
245 10 - TITLE STATEMENT |
Title |
Cardiovascular Complications of COVID-19 |
Medium |
[electronic resource] : |
Remainder of title |
Risk, Pathogenesis and Outcomes / |
Statement of responsibility, etc. |
by Umair Mallick. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Epidemiology -- Virology Of COVID 19 -- Clinical Features And Complications Of COVID 19.-Treatment Options In Covid 19 -- Inflammation And COVID 19 -- Renin Angiotensin System And COVID 19 -- Pathogenetic Mechanisms In Non-Cardiovascular Complications -- Cytokines And Viral Damage In COVID 19 -- Thrombosis In COVID 19 -- Angiotensin Converting Enzyme 2 In COVID 19 -- Regulatory Systems And COVID 19 -- Miscellaneous Novel Mechanisms In COVID 19 -- Myocardial Injury And Acute Coronary Syndromes In COVID 19 -- Heart Failure, Hypertension And Arrhythmias In COVID 19 -- Patients With Cardiometabolic Diseases And COVID 19 -- Older Age And COVID 19 -- Gender Dichotomy And COVID 19 -- Quality Of Research In COVID 19 -- Conclusion. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This book discusses the evidence behind the relationship between COVID-19 and heart disease based on emerging state-of-the-art data. The rapid and unexpected global spread of the COVID-19 has revealed proportional levels of cardiovascular and metabolic complications. A myriad of pathogenetic mechanisms has come to the surface. There is still much research required to define whether cardiovascular disease causes COVID-19 complications or that cardiovascular disease appears as a result of the infection and which mechanisms are responsible. With cardiovascular and metabolic diseases already at pandemic levels and expected to increase further, this book provides readers with an urgent and thorough analysis of this association. Cardiovascular Complications of COVID-19: Risk, Pathogenesis and Outcomes provides answers to the increasing numbers of questions related to heart disease in COVID-19, highlighting the association between these pandemics and including risk factors, mechanisms and how these may impact diverse patients populations. It describes how COVID-19 impacts older patients and those with metabolic illnesses such as obesity and diabetes mellitus, while providing an overview of the observed gender dichotomy among patients. It therefore represents an essential resource not only for all cardiovascular physicians but also for any healthcare professionals managing patients with these diseases or those exploring COVID-19. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cardiology. |
|
Topical term or geographic name entry element |
Public health. |
|
Topical term or geographic name entry element |
Epidemiology. |
|
Topical term or geographic name entry element |
Cardiology. |
|
Topical term or geographic name entry element |
Public Health. |
|
Topical term or geographic name entry element |
Epidemiology. |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
COVID-19 -- complications |
|
Uncontrolled term |
Cardiovascular Diseases -- etiology |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-90065-6">https://doi.org/10.1007/978-3-030-90065-6</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |